Table 3 miRNAs differentially expressed in triple negative breast cancer patients with lymph node metastases

hsa-let-7a

−2.36

0.00419

−3.33

0.00042

1.05

ns

hsa-let-7b

−2.99

0.00011

−4.67

0.00007

−1.30

ns

hsa-let-7c

−3.84

0.00006

−6.34

0.00001

−1.72

ns

hsa-miR-100

−4.37

0.00176

−4.57

0.00331

−1.84

ns

hsa-miR-101

−2.61

0.01750

−3.30

0.02278

1.22

ns

hsa-miR-10a

−2.37

0.02228

−4.64

0.00496

−1.78

ns

hsa-miR-125b

−5.18

0.00010

−8.41

0.00001

−2.69

ns

hsa-miR-126

−2.72

0.00451

−3.76

0.00451

−1.50

ns

hsa-miR-126*

−2.31

0.04409

−2.63

0.02725

−1.56

ns

hsa-miR-130a

−3.32

0.01446

−6.61

0.00430

−1.32

ns

hsa-miR-135b

14.14

0.00012

6.92

0.02725

14.87

ns

hsa-miR-136

−6.18

0.00011

−9.58

0.00223

−3.42

ns

hsa-miR-143

−2.99

0.01750

−3.04

0.03718

−2.02

ns

hsa-miR-195

−5.70

0.00006

−10.02

0.00029

−2.50

ns

hsa-miR-1977_v14.0

−2.28

0.00377

−2.91

0.00069

−1.49

ns

hsa-miR-199a-3p

−2.50

0.01750

−4.84

0.00451

−1.55

ns

hsa-miR-199a-5p

−2.46

0.04409

−4.64

0.00869

−1.66

ns

hsa-miR-199b-5p

−5.66

0.00011

−9.29

0.00021

−3.40

ns

hsa-miR-205

−4.65

0.02890

−5.18

0.01648

−1.82

ns

hsa-miR-210

4.56

0.00862

2.98

0.02389

4.01

ns

hsa-miR-214

−2.64

0.01360

−3.64

0.02023

−2.28

ns

hsa-miR-26a

−2.67

0.01428

−3.84

0.00247

−1.00

ns

hsa-miR-26b

−2.43

0.01681

−3.01

0.01308

−1.01

ns

hsa-miR-29c

−2.33

0.04343

−2.69

0.03676

−1.12

ns

hsa-miR-320c

−2.15

0.02461

−2.65

0.02023

−1.02

ns

hsa-miR-34a

−2.12

0.02087

−3.59

0.00825

−1.11

ns

hsa-miR-497

−5.11

0.00006

−7.91

0.00029

−2.06

ns